7 AveryJ
Studies comparing DPP-IV inhibitors with GLP-1 receptor (GLP-1R) agonists have shown greater weight loss and reduction in glucose excursions in individuals treated with GLP-1R agonists [20]
Many users report that nausea on tirzepatide is most intense during the first few weeks of starting or after a dosage increase
Moreno et al., 2021), continuing programs that were previously in development, such as "One Square in Each Neighbourhood", implemented to reinforce micro-centralities and upgrade public spaces for community interaction
Though not directly affecting thyroid hormones, it may mitigate secondary effects of hyperthyroidism, such as muscle wasting and immune suppression (Yance, 2013)
Drug is not yet FDA approved, so is not yet a component of an FDA-approved drug therefore is not yet eligible for compounding by state-licrnsed pharmacies under FD&C Act